Pediatric Early Rehabilitation in Acute Lymphoblastic Leukemia

Launched by UNIVERSITY OF ALBERTA · Dec 6, 2023

Keywords

ClinConnect Summary

This clinical trial is looking at a new way to help children with acute lymphoblastic leukemia (ALL) through a blend of in-person and online physiotherapy sessions. The program, called HEAL-ME, aims to see how well this hybrid approach works and whether children and their families find it acceptable and easy to participate. The researchers will track how many sessions each child completes and which resources they use on the online platform, helping to understand if this kind of therapy is beneficial for young patients.

To join the study, children must be between 4 and 17 years old, diagnosed with ALL, and either currently undergoing treatment or have completed it. They also need to have internet access at home and be able to communicate in English. Parents or caregivers will be involved in the program as well. Participants can expect to engage in personalized physiotherapy exercises, both online and in-person, designed to support their recovery. It's important to note that children with certain developmental disorders or other serious conditions may not be eligible for this study.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Children diagnosed with acute lymphoblastic leukemia aged between 4 and 17 years (at time of diagnosis) and their mother, father, or primary carer;
• • 2. Undergoing or completed cancer treatment as established by the Children's Oncology Group;
• • 3. Access to the internet through a home computer or tablet;
• • 4. Patient or caregiver is able to speak and comprehend English; and
• • 5. The child is approved by their Oncologist to participate in the program.
• Exclusion Criteria:
• • 1. Children with a history of a neurodevelopmental or genetic disorder (i.e., Down syndrome, autism, seizure disorder) prior to the cancer diagnosis; and
• • 2. Children with a concurrent condition (illness, disease, psychiatric disorder), as determined by oncologist or physiotherapist, that would compromise study participation or interpretation of study results.